Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

60 trials found

Recruiting 60,000 target

Vermont Oxford Network Very Low Birth Weight Database

Vermont Oxford Network

NCT01825499

Recruiting 1,500 target

Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study

White River Junction Veterans Affairs Medical Center

NCT04220905

Recruiting 1,000 target

Deep Functional Phenotyping of the ALA Lung Health Cohort

Johns Hopkins University

NCT06177717

Recruiting 1,000 target

International CIPN Assessment and Validation Study

University of Milano Bicocca

NCT04633655

Recruiting 1,000 target

PanTheR Registry Trial

RenovoRx

NCT06805461

Recruiting Phase 3 996 target

DOAC - Dosing Options in AntiCoagulation Prophylaxis

University of Vermont

NCT07005024

Recruiting Phase 3 994 target

Prehospital Analgesia INtervention Trial (PAIN)

Jason Sperry

NCT05437575

Recruiting Phase 4 952 target

A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

VA Office of Research and Development

NCT04375033

Recruiting NA 700 target

ELEVATE-HFpEF Clinical Study

Medtronic Cardiac Rhythm and Heart Failure

NCT06678841

Recruiting 450 target

Longitudinal Bladder Cancer Study for Tumour Recurrence

Pacific Edge Limited

NCT05080998

Recruiting NA 422 target

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

University of Vermont

NCT04763356

Recruiting Phase 2 308 target

Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes

University of Vermont

NCT06614504

Recruiting 300 target

Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy

Dana-Farber Cancer Institute

NCT04968834

Recruiting Phase 2 300 target

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

Exciva

NCT07284472

Recruiting Phase 3 264 target

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

NCT06463587

Recruiting Phase 3 256 target

Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer

Laekna Limited

NCT04851613

Recruiting Phase 1 255 target

Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

Vertex Pharmaceuticals Incorporated

NCT06154447

Recruiting NA 245 target

Endocardial Mapping With the CoreMap EP Mapping System

CoreMap

NCT06529978

Recruiting Phase 2 240 target

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

White River Junction Veterans Affairs Medical Center

NCT05796375

Recruiting NA 240 target

PRESERVE & CONNECT: Impact Study of the BPC

University of Vermont

NCT06160050

Recruiting NA 240 target

Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)

University of Vermont Medical Center

NCT07072377

Recruiting Phase 3 210 target

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age

Vertex Pharmaceuticals Incorporated

NCT05422222

Recruiting Phase 1 200 target

LEMURS SSI: Evaluation of Behavioral Incentives

University of Vermont

NCT06340841

Recruiting NA 162 target

Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes

UNC Lineberger Comprehensive Cancer Center

NCT07061652

Recruiting NA 135 target

Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD

University of Vermont

NCT06288711

Recruiting Phase 2 130 target

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Johnson & Johnson Enterprise Innovation

NCT06667908

Recruiting NA 120 target

Suicide Prevention After Community Care Discharge

VA Office of Research and Development

NCT06596044

Recruiting Phase 3 120 target

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Janssen Research & Development

NCT05923073

Recruiting NA 120 target

His-Bundle Corrective Pacing in Heart Failure

University of Rochester

NCT05265520

Recruiting NA 114 target

Optimizing Aerobic Fitness in Older Adults

University of Vermont Medical Center

NCT06951620

Recruiting Phase 3 110 target

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

Cardiol Therapeutics

NCT06708299

Recruiting NA 105 target

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

Medtronic Cardiac Rhythm and Heart Failure

NCT05839730

Recruiting Phase 2 103 target

Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial

University of Vermont Medical Center

NCT06778408

Recruiting Phase 2 100 target

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Prakash Pandalai

NCT04779554

Recruiting Phase 2 92 target

Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder

White River Junction Veterans Affairs Medical Center

NCT05637879

Recruiting Phase 3 90 target

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Eli Lilly and Company

NCT05509777

Recruiting 80 target

Sinus Disease in Young Children With Cystic Fibrosis

University of California, Los Angeles

NCT06191640

Recruiting NA 68 target

Comparing the Effectiveness of the 'Think in Nerve Length and Layers' (TINLL) Approach to Traditional Treatment for Patients With Lateral Elbow Pain.

University of Vermont

NCT07385677

Recruiting Phase 2 66 target

Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer

BicycleTx Limited

NCT06840483

Recruiting NA 60 target

Fatty Acid Modulation of Brain Function in Older Adults

University of Vermont

NCT06192407

Recruiting Phase 1 60 target

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Memorial Sloan Kettering Cancer Center

NCT06934889

Recruiting Phase 3 59 target

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Takeda

NCT06747351

Recruiting NA 50 target

Remote Smoking Cessation in Hospitalized Cardiac Patients

University of Vermont Medical Center

NCT05738408

Recruiting Phase 2 40 target

Venous Thromboembolism Prevention in Outpatients With Glioma

University of Vermont Medical Center

NCT05683808

Recruiting NA 40 target

Multi-disciplinary Care for Brain Metastases

University of Vermont Medical Center

NCT06280300

Recruiting NA 40 target

Care Coordination Educational Intervention Study for Patients from Rural Areas with Early Stage Cancer

University of Vermont Medical Center

NCT05723250

Recruiting Phase 1 40 target

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

Chris Goss

NCT04294043

Recruiting NA 40 target

Food Insecurity and Eating Behavior Among Adults Receiving Buprenorphine or Methadone Maintenance Treatment: Pilot Study 2

University of Vermont

NCT07251283

Recruiting Phase 1 39 target

DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

Delta-Fly Pharma

NCT06382168

Recruiting Phase 2 32 target

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

University of Vermont

NCT06972875

Recruiting 30 target

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

University of Vermont

NCT06692894

Recruiting NA 30 target

Avocado and Postprandial Responses

University of Vermont Medical Center

NCT06818032

Recruiting NA 30 target

Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)

Dartmouth-Hitchcock Medical Center

NCT05302375

Recruiting Phase 2 28 target

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Providence Health & Services

NCT06175000

Recruiting NA 20 target

Transcranial Magnetic Stimulation in Veterans With PTSD

White River Junction Veterans Affairs Medical Center

NCT07336251

Recruiting NA 20 target

Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure

IDeA States Pediatric Clinical Trials Network

NCT06423664

Recruiting NA 20 target

Choline Dose Ranging in Postmenopausal Women

Julie Dumas

NCT06924541

Recruiting NA 20 target

Accelerated Pulmonary Rehabilitation in the Preoperative Period

University of Vermont

NCT06432972

Recruiting Phase 2 16 target

Pyridostigmine for the Treatment of Constipation in Parkinson Disease

University of Vermont Medical Center

NCT05603715

Recruiting NA 8 target

Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia

University of Vermont

NCT05452226

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →